1. What We Do

Disease Prevention and Control Project

Abstract*

The development objective of the Disease Prevention and Control Project for Armenia is to improve (i) Maternal and Child Health (MCH) services and the prevention, early detection, and management of selected Non-Communicable Diseases (NCD) at the Primary Health Care (PHC) level; and (ii) the efficiency and quality of selected hospitals in Armenia. The project has three components. Component 1 is Performance-based Financing (PBF) scheme to improve MCH...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The objective of the Project is to (i) increase the detection of selected NCDs at the PHC level and among pregnant mothers; (ii) improve the efficiency and quality of selected hospitals; and (iii) prevent, detect and respond to the threat posed by COVID-19.

Key Details

Project Details

  • P128442

  • Closed

  • Christine Pena

  • Republic of Armenia

  • Armenia

  • April 2, 2012

  • (as of board presentation)

    March 27, 2013

  • July 22, 2013

  • US$ 45.00 million

  • Ministry of Health, HPIU

  • Europe and Central Asia

  • 2013

  • US$ 36.80 million

  • B

  • March 28, 2024

  • June 30, 2024

  • Yes

  • BANK APPROVED

  • Notes

Sectors

Created with Highstock 5.0.14FY17 - Tertiary EducationFY17 - Public Administration -HealthFY17 - Public Administration - HealthFY17 - Health

Themes

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Health Results-based Financing 1.80
IDA Credit 35.00
Borrower/Recipient 8.20

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 35.00
IBRD + IDA Commitment 35.00
Lending Instrument
Grant Amount 1.80
Total Project Cost** 45.00

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
May 15, 2023 IBRD-92020 Int Charges 94,307.22
Jan 31, 2023 IDA-52220 Loan Cancel 7,482.39
Feb 23, 2023 IBRD-92020 Loan Disb 600,000.00
Aug 11, 2023 IBRD-92020 Loan Disb 1,081,905.20
Jun 27, 2023 IBRD-92020 Loan Disb 1,047,576.30
Nov 10, 2023 IBRD-92020 Loan Disb 232,281.62
Nov 15, 2023 IDA-52220 Int Charges 8,317.83
Nov 15, 2023 IDA-52220 Int Charges 92,793.28
Nov 15, 2023 IDA-52220 Int Charges 92,793.28
Nov 15, 2023 IDA-52220 Int Charges 257,029.61
Nov 15, 2023 IDA-52220 Int Charges 102,406.24
Nov 15, 2023 IDA-52220 Loan Repay 498,827.44
Nov 15, 2023 IBRD-92020 Int Charges 150.96
Nov 15, 2023 IBRD-92020 Int Charges 5,757.49
Nov 15, 2023 IBRD-92020 Int Charges 1,245.43
Nov 15, 2023 IBRD-92020 Int Charges 209,185.98
May 15, 2024 IBRD-92020 Int Charges 1,432.49
May 8, 2020 IDA-52220 Loan Disb 209,734.88
Jun 17, 2020 IDA-52220 Loan Disb 333,606.70
May 26, 2020 IDA-52220 Loan Disb 166,752.00
May 15, 2020 IDA-52220 Int Charges 92,643.43
May 15, 2020 IDA-52220 Int Charges 92,643.43
May 15, 2020 IDA-52220 Int Charges 364,397.47
Jun 4, 2020 IDA-52220 Loan Disb 87,775.99
May 15, 2020 IDA-52220 Int Charges 1,223.26
May 15, 2020 IDA-52220 Loan Repay 511,402.53
Jun 9, 2020 IDA-52220 Loan Disb 410,329.16
Jul 15, 2020 IDA-52220 Loan Disb 708,847.75
Dec 9, 2020 IDA-52220 Loan Disb 1,784,029.40
May 15, 2021 IDA-52220 Loan Repay 541,238.94
May 15, 2021 IDA-52220 Int Charges 174,041.23
Jun 14, 2021 IBRD-92020 Loan Disb 18,500.00
Jun 14, 2021 IBRD-92020 Fee Charges 18,500.00
Nov 15, 2020 IDA-52220 Loan Repay 13,236.34
Nov 15, 2020 IDA-52220 Int Charges 101,438.60
Nov 15, 2020 IDA-52220 Int Charges 101,438.60
Nov 15, 2020 IDA-52220 Int Charges 396,674.75
Nov 15, 2020 IDA-52220 Loan Repay 520,899.94
May 5, 2021 IDA-52220 Loan Disb 260,000.00
May 15, 2017 IDA-52220 Int Charges 60,538.86
Nov 15, 2017 IDA-52220 Int Charges 73,553.47
Nov 15, 2017 IDA-52220 Int Charges 73,553.47
Sep 6, 2013 IDA-52220 Loan Disb 1,368,090.20
Sep 6, 2013 IDA-52220 Loan Disb 42,375.59
Aug 27, 2013 IDA-52220 Loan Disb 2,500,000.00
Dec 9, 2014 IDA-52220 Loan Disb 285,271.28
Nov 15, 2014 IDA-52220 Int Charges 319.91
Nov 15, 2014 IDA-52220 Int Charges 319.91
Nov 15, 2014 IDA-52220 Int Charges 17,336.00
Nov 15, 2014 IDA-52220 Int Charges 17,336.00
Nov 15, 2014 IDA-52220 Int Charges 29,426.49
Dec 27, 2013 IDA-52220 Loan Disb 228,528.16
Jun 2, 2014 IDA-52220 Loan Disb 617,160.80
May 15, 2014 IDA-52220 Int Charges 6,194.17
May 15, 2014 IDA-52220 Int Charges 6,194.17
May 15, 2014 IDA-52220 Int Charges 10,323.66
May 15, 2014 IDA-52220 Int Charges 15,574.11
May 15, 2014 IDA-52220 Int Charges 15,574.11
May 15, 2014 IDA-52220 Int Charges 25,956.84
Sep 11, 2014 IDA-52220 Loan Disb 530,271.20
Mar 16, 2015 IDA-52220 Loan Disb 248,949.48
Jul 8, 2015 IDA-52220 Loan Disb 373,141.00
May 15, 2015 IDA-52220 Int Charges 18,558.23
May 15, 2015 IDA-52220 Int Charges 18,558.23
May 15, 2015 IDA-52220 Int Charges 30,351.05
May 15, 2015 IDA-52220 Int Charges 1,146.09
May 15, 2015 IDA-52220 Int Charges 1,146.09
Nov 15, 2015 IDA-52220 Int Charges 2,433.43
Nov 15, 2015 IDA-52220 Int Charges 21,686.04
Nov 15, 2015 IDA-52220 Int Charges 21,686.04
Nov 15, 2015 IDA-52220 Int Charges 35,454.65
Dec 8, 2015 IDA-52220 Loan Disb 570,023.06
Oct 13, 2015 IDA-52220 Loan Disb 1,035,293.80
Feb 2, 2016 IDA-52220 Loan Disb 1,175,279.50
May 15, 2024 IBRD-92020 Int Charges 254,066.66
May 15, 2024 IDA-52220 Int Charges 5,538.19
May 15, 2024 IBRD-92020 Int Charges 7.95
May 15, 2024 IDA-52220 Int Charges 356,812.06
May 15, 2024 IDA-52220 Loan Repay 495,263.72
May 15, 2024 IDA-52220 Loan Repay 2,424.16
May 15, 2024 IDA-52220 Int Charges 90,714.94
May 15, 2024 IDA-52220 Int Charges 90,714.94
Feb 4, 2021 IBRD-92020 Loan Commitment 7,400,000.00
Mar 27, 2013 IDA-52220 Loan Commitment 35,000,000.00
Mar 21, 2022 IDA-52220 Loan Disb 9,000.00
Nov 15, 2022 IBRD-92020 Int Charges 434.02
Nov 15, 2022 IBRD-92020 Int Charges 6,649.66
Nov 15, 2022 IBRD-92020 Int Charges 37,085.48
Nov 15, 2022 IBRD-92020 Int Charges 105.59
Nov 15, 2022 IDA-52220 Loan Repay 467,301.60
Nov 7, 2022 IBRD-92020 Loan Disb 588,318.30
Nov 15, 2022 IDA-52220 Int Charges 95,666.20
Nov 15, 2022 IDA-52220 Int Charges 95,666.20
Nov 15, 2022 IDA-52220 Int Charges 147,438.23
Nov 15, 2022 IDA-52220 Loan Repay 27,766.34
Dec 7, 2022 IBRD-92020 Loan Disb 401,809.88
May 15, 2023 IDA-52220 Int Charges 368,503.03
Apr 27, 2023 IBRD-92020 Loan Disb 1,224,494.10
May 15, 2023 IBRD-92020 Int Charges 32.24
May 15, 2023 IBRD-92020 Int Charges 3,782.36
May 15, 2023 IBRD-92020 Int Charges 4,766.52
May 15, 2023 IDA-52220 Int Charges 12,248.90
May 15, 2023 IDA-52220 Loan Repay 504,961.47
May 15, 2023 IDA-52220 Int Charges 95,827.90
May 15, 2023 IDA-52220 Int Charges 95,827.90
May 15, 2021 IDA-52220 Int Charges 108,056.20
May 15, 2021 IDA-52220 Int Charges 108,056.20
May 15, 2021 IDA-52220 Int Charges 2,347.94
Oct 27, 2021 IBRD-92020 Loan Disb 661,459.40
Oct 27, 2021 IBRD-92020 Loan Disb 2,797.48
Oct 18, 2021 IBRD-92020 Loan Disb 900,000.00
Nov 15, 2021 IDA-52220 Loan Repay 528,534.70
Nov 15, 2021 IDA-52220 Int Charges 105,312.93
Nov 15, 2021 IDA-52220 Int Charges 105,312.93
Nov 15, 2021 IDA-52220 Int Charges 175,521.56
Nov 15, 2021 IDA-52220 Int Charges 5,910.32
May 15, 2022 IBRD-92020 Int Charges 1,022.65
May 15, 2022 IBRD-92020 Int Charges 7,106.21
May 15, 2022 IBRD-92020 Int Charges 10,026.75
May 15, 2022 IBRD-92020 Int Charges 259.05
Nov 15, 2021 IBRD-92020 Int Charges 10,365.26
Nov 15, 2021 IBRD-92020 Int Charges 96.57
Jun 10, 2022 IDA-52220 Loan Disb 221,500.00
Mar 22, 2022 IBRD-92020 Loan Disb 285,502.16
May 15, 2022 IDA-52220 Int Charges 97,886.32
May 15, 2022 IDA-52220 Int Charges 97,886.32
May 15, 2022 IDA-52220 Int Charges 163,143.88
Jul 19, 2022 IBRD-92020 Loan Disb 355,355.44
May 15, 2022 IDA-52220 Loan Repay 488,408.78
May 15, 2022 IDA-52220 Loan Repay 12,226.89
Nov 15, 2017 IDA-52220 Int Charges 122,589.15
Nov 15, 2017 IDA-52220 Int Charges 4,902.18
Nov 22, 2017 IDA-52220 Loan Disb 1,395,136.20
Aug 23, 2017 IDA-52220 Loan Disb 557,934.30
Jan 16, 2018 IDA-52220 Loan Disb 1,290,203.90
Jan 16, 2018 IDA-52220 Loan Disb 1,078,272.20
May 22, 2018 IDA-52220 Loan Disb 938,186.50
May 15, 2018 IDA-52220 Loan Repay 1,546.68
May 15, 2018 IDA-52220 Loan Repay 535,749.70
May 15, 2018 IDA-52220 Int Charges 86,422.58
May 15, 2018 IDA-52220 Int Charges 86,422.58
May 15, 2018 IDA-52220 Int Charges 144,037.56
Nov 15, 2018 IDA-52220 Loan Repay 13,476.67
Nov 15, 2018 IDA-52220 Loan Repay 506,307.60
Nov 15, 2018 IDA-52220 Int Charges 88,614.64
Nov 15, 2018 IDA-52220 Int Charges 88,614.64
Nov 15, 2018 IDA-52220 Int Charges 220,797.45
Nov 15, 2018 IDA-52220 Int Charges 127,753.48
Jan 28, 2019 IDA-52220 Loan Disb 919,925.70
Oct 29, 2018 IDA-52220 Loan Disb 1,755,086.50
Jun 10, 2019 IDA-52220 Loan Disb 223,232.16
May 15, 2019 IDA-52220 Int Charges 94,853.42
May 15, 2019 IDA-52220 Int Charges 373,090.03
May 15, 2019 IDA-52220 Loan Repay 508,389.06
May 15, 2019 IDA-52220 Loan Repay 11,643.48
May 15, 2019 IDA-52220 Int Charges 94,853.42
Nov 15, 2019 IDA-52220 Int Charges 94,527.32
Nov 15, 2019 IDA-52220 Int Charges 94,527.32
Nov 15, 2019 IDA-52220 Int Charges 370,570.60
Oct 1, 2019 IDA-52220 Loan Disb 61,000.86
Nov 15, 2019 IDA-52220 Loan Repay 509,922.03
Nov 15, 2019 IDA-52220 Loan Repay 7,168.63
Feb 12, 2020 IDA-52220 Loan Disb 393,605.72
Jun 15, 2016 IDA-52220 Loan Disb 1,176,210.60
Jul 7, 2016 IDA-52220 Loan Disb 1,395,205.10
Jul 28, 2016 IDA-52220 Loan Disb 1,102,634.90
Jul 21, 2016 IDA-52220 Loan Disb 1,055,021.60
May 10, 2016 IDA-52220 Loan Disb 812,511.44
May 15, 2016 IDA-52220 Int Charges 702.11
May 15, 2016 IDA-52220 Int Charges 30,274.05
May 15, 2016 IDA-52220 Int Charges 30,274.05
May 15, 2016 IDA-52220 Int Charges 49,239.47
Sep 13, 2016 IDA-52220 Loan Disb 1,335,365.20
Jun 29, 2016 IDA-52220 Loan Disb 895,718.44
Nov 15, 2016 IDA-52220 Int Charges 1,176.36
Nov 15, 2016 IDA-52220 Int Charges 50,486.09
Nov 15, 2016 IDA-52220 Int Charges 50,486.09
Nov 15, 2016 IDA-52220 Int Charges 84,143.50
Dec 22, 2016 IDA-52220 Loan Disb 1,093,087.20
Apr 21, 2017 IDA-52220 Loan Disb 1,636,881.90
May 15, 2017 IDA-52220 Int Charges 3,661.20
May 15, 2017 IDA-52220 Int Charges 3,661.20
May 15, 2017 IDA-52220 Int Charges 102,245.67
May 15, 2017 IDA-52220 Int Charges 60,538.86
Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2024-06-27
Monitoring and Evaluation Satisfactory 2024-06-27
Overall Implementation Progress (IP) Satisfactory 2024-06-27
Project Management Satisfactory 2024-06-27
Overall Safeguards Rating Satisfactory 2024-06-27
Procurement Satisfactory 2024-06-27
Financial Management Satisfactory 2024-06-27

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of antenatal care (ANC) attendees screened for glycosuria, hypertension and proteinuria in at least three antenatal visits (Percentage)Value0.0094.8085.00
    DateJanuary 23, 2013December 31, 2022June 30, 2024
    Comment
  • Bed occupancy rate at the a) Artashat Medical Center; b) Sevan Medical Center (Percentage)Valuea)64.00b)51.00a) 58.7b) 61.9a)70.00 b)70.00
    DateJanuary 23, 2013August 31, 2023June 30, 2024
    Comment
  • Number of designated intensive care units that are fully equipped and functional, without stock-outs in the final two weeks of the calendar year (Number)Value0.005.004.00
    DateJanuary 23, 2013December 31, 2022June 30, 2024
    Comment
  • Percentage of population aged 35-68 screened for hypertension at least once in the last year a) female; b) male (Percentage)Valuea) 22.50b) 17.80a) 40.2 b) 26.7a)39.00b)27.00
    DateDecember 31, 2013December 31, 2022June 30, 2024
    Comment
  • Percentage of deaths following hospital discharges for acute myocardial infarction or pneumonia, in the last year, at Sevan and Artashat MCs (Percentage)Value10.603.608.00
    DateDecember 31, 2013October 4, 2023June 30, 2024
    Comment
  • Percentage of population aged 35-68 screened for diabetes mellitus at PHC level at least once during the last 3 years a) female; b)male (Percentage)Valuea)9.80b)7.50a) 23.1 b) 14.8a)20.00b)15.00
    DateDecember 31, 2013December 31, 2022June 30, 2024
    Comment
  • Percentage of women aged 30-60 screened for cervical cancer at least once during the last 3 years and received the results (Percentage)Value8.509.7010.00
    DateJanuary 23, 2013December 31, 2022June 30, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of PHC facilities undergoing enhanced verification of results by the HPIU (Percentage)Value0.0098.3098.00
    DateJanuary 23, 2013December 31, 2022June 30, 2024
    Comment
  • Health facilities constructed, renovated, and/or equipped (Number)Value0.005.006.00
    DateJanuary 23, 2013November 15, 2023June 30, 2024
    Comment
  • Number of ventilators for management of COVID-19 cases, financed through the Project (Number)Value0.0070.0070.00
    DateJanuary 23, 2013December 31, 2022June 30, 2024
    Comment
  • Percentage of adults aware of key NCD risk factors a) high blood pressure; b) high cholesterol level; c) high salt intake; d) obesity; e) high glucose level (disaggregated by gender) (Percentage)ValueMalea)45.00b)24.00c)55.00d)65.00e)33.00FemaMale a) 27.4 b) 12.5c) 75.7d) 63.5 e) 18.3FMalea)47.00b)26.00c)57.00d)66.00e)35.00Fema
    DateJanuary 31, 2013December 31, 2022June 30, 2024
    Comment
  • Number of hospital health workers receiving training on new clinical practice guidelines (Number)Value0.00316.00300.00
    DateJanuary 23, 2013December 31, 2022June 30, 2024
    Comment
  • Medical Centers operational a) Sevan MC; b) Artashat MC; c) Martuni MC; d) Vayots Dzor MC (Text)Valuea)Not operational b)Not operational c)Not operata) Operational b) Operational c) Operationald) a)Operational b)Operational c)Operational d)Ope
    DateJanuary 23, 2013November 15, 2023June 30, 2024
    Comment
  • Percentage of workers under the Project with adequate awareness of GBV, including SEA and SH, in the last year: a) Male; b) Female (Percentage)Valuea)9.50 b)14.20a) 73.2 b) 86.7a)70.00b)80.00
    DateOctober 31, 2020December 31, 2022June 30, 2024
    Comment
  • Percentage of beneficiaries in annual consultations that express satisfaction with the Project, including the community engagement process: (a) Gegharkunik Marz (b) Vayots Dzor Marz (Percentage)Valuea)0.00 b)0.00a) 100.00 b) 100.00a)60.00b)60.00
    DateOctober 31, 2020December 31, 2022June 30, 2024
    Comment